Christopher R. Fenimore - Mar 23, 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**Christopher R. Fenimore
Stock symbol
REGN
Transactions as of
Mar 23, 2023
Transactions value $
-$1,767,782
Form type
4
Date filed
3/27/2023, 04:37 PM
Previous filing
Feb 7, 2023
Next filing
Aug 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale -$1.77M -2.19K -10.64% $806.47 18.4K Mar 23, 2023 Direct F1
holding REGN Common Stock 1.47K Mar 23, 2023 2021 GRAT
holding REGN Common Stock 5K Mar 23, 2023 2022 GRAT
holding REGN Common Stock 1.48K Mar 23, 2023 By 401(k) Plan
holding REGN Common Stock 1.9K Mar 23, 2023 By Trust F2
holding REGN Common Stock 461 Mar 23, 2023 by Trust for Daugh
holding REGN Common Stock 460 Mar 23, 2023 by Trust for Son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 9, 2023.
F2 These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.